Analysis to Inform Decisions: Evaluating BSE Joshua Cohen and George Gray Harvard Center for Risk Analysis Harvard School of Public Health.

Slides:



Advertisements
Similar presentations
Bovine Spongiform Encephalopathy (BSE) in Canada Pedro Piccardo, MD Division of Emerging and Transfusion-Transmitted Diseases Office of Blood Research.
Advertisements

Update on PEDV Lisa Becton, DVM, MS National Pork Board.
Proposed SRM Disposal Permitting Process Natalie Bragg, D.V.M., M.Sc., Animal Health and Production Canadian Food Inspection Agency.
Research on Pre-Movement Testing in Ireland Tracy Clegg Centre for Veterinary Epidemiology and Risk Analysis, University College Dublin.
Sensitivity Analysis for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Mad Cow Disease 袁聖甯 黃竹瑄 鄧雯心. What is Mad Cow Disease ? A kind of transmissible spongiform encephalopathies (TSE) Occurs in many mammals, including human.
A Brief Introduction to Epidemiology - VII (Epidemiologic Research Designs: Demographic, Mortality & Morbidity Studies) Betty C. Jung, RN, MPH, CHES.
Are humans susceptible?
Joining the links of a Greener meat chain Stephen Woodgate, Chief Executive.
Food Safety Risk Assessment - PubH of 40 Overview of 3 published risk assessments Don Schaffner, Ph.D. Rutgers, The State University of NJ.
Foreign Animal Disease Angie Dement Extension Associate for Veterinary Medicine Texas AgriLife Extension Service College of Veterinary Medicine and Biomedical.
Bovine Spongiform Encephalopathy Luke VanNatter Carrie Pell Amy Richwine Scott Inskeep Kristina Anderson.
Foot and Mouth Analysis Mike Delorme Rachelle Miron.
Mad Cow Disease. Effects of Mad Cow disease Mad cow disease, or bovine spongiform encephalopathy (BSE), is a fatal brain disorder that occurs in cattle.
Risk Assessment: A Conceptual Introduction
Bovine Spongiform Encepalopathy, BSE Should FAO have maintained its silence?
Harvard Center for Risk Analysis Evaluation of the Potential for BSE in the United States Joshua T. Cohen Keith Duggar George M. Gray Silvia Kreindel Harvard.
Canadian and U.S. BSE Risk Steven Anderson, Ph.D, MPP Office of Biostatistics & Epidemiology Center for Biologics Evaluation & Research U.S. Food & Drug.
Prion Diseases Microbes and Society Fall What is a Prion? Prion- small proteinaceous infectious particles which resist inactivation by procedures.
BOVINE SPONGIFORM ENCEPHALOPATHY (BSE) or “Mad Cow Disease”: Cause and effect on the beef market. Name: Odette K Busambwa.
Chapter 8 Introduction to Hypothesis Testing
1 Harvard Risk Assessment of Bovine Spongiform Encephalopathy (BSE) Joshua T. Cohen, Ph.D. The Center for the Evaluation of Value and Risk Institute for.
Kathleen Orloski, DVM, MS Diplomate, ACVPM, Epidemiology Specialty USDA, APHIS, Veterinary Services TB Eradication Program April 5-6, 2011.
Practical Applications for Managing Biological Risks Aerosol Transmission Beef Producers.
Teaching Workshop Bovine Spongiform Encephalopathy (BSE)
Canada’s BSE Story Presentation to the Ontario Association of Bovine Practitioners November 6, 2003.
BSE in the US APHIS Investigation and Response FDA TSE Advisory Committee February 12, 2004 Lisa A. Ferguson, DVM Senior Staff Veterinarian USDA, APHIS,
Prions: Proteins Gone Bad
FVIII PRODUCT USAGE IN CLINICAL SETTINGS TSEAC October 31, 2005 Mark Weinstein, Ph.D. Office of Blood Research and Review CBER, FDA.
Finding Real World Solutions for Animal ID. NWPP Major Milestones March 2004: Cattle associations visit with Bill Hawks and Keith Collins of the USDA.
Risk Assessments: Models for Estimating the Risk of Transmitting TSE by Human Tissue Intended for Transplantation Rolf E. Taffs, Ph.D. Center for Biologics.
January 2002 WHO/CSR/APH Efforts and needs for global control of BSE and vCJD Maura N. Ricketts MD MHSc FRCPC WHO/CDS/CSR/EPH.
Proposed algorithm for approval of human TSE tests in Europe.
Module 3 Risk Analysis and its Components. Risk Analysis ● WTO SPS agreement puts emphasis on sound science ● Risk analysis = integrated mechanism to.
BSE: World Situation and USDA Response FDA TSE Advisory Committee Silver Spring, MD October 14, 2004 Lisa A. Ferguson, DVM Senior Staff Veterinarian USDA,
Chronic Wasting Disease (CWD) David Litts. What is it? Prions (infectious incomplete protein) Prions (infectious incomplete protein) Creutzfeldt-jakob.
A Stochastic Model of Paratuberculosis Infection In Scottish Dairy Cattle I.J.McKendrick 1, J.C.Wood 1, M.R.Hutchings 2, A.Greig 2 1. Biomathematics &
Teaching Workshop Bovine Spongiform Encephalopathy (BSE) Advanced Meat Recovery (AMR)
Epidemiology: Basic concepts and principles ENV
Risk-Based Sourcing for Bovine Materials in FDA-regulated Medical Products: Introduction and General Considerations FDA TSE Advisory Committee Meeting.
Practical Applications for Managing Biological Risks
Dynamic Random Graph Modelling and Applications in the UK 2001 Foot-and-Mouth Epidemic Christopher G. Small Joint work with Yasaman Hosseinkashi, Shoja.
Risk Assessment* and Zoonotic Implications Yvonne Nadler DVM MPH April 6, 2011 * THE FUN STUFF.
TSE Advisory Committee October 25, 2001 Center for Food Safety and Applied Nutrition Food and Drug Administration Washington, DC Topic 3.
AUSTRALIA INDONESIA PARTNERSHIP FOR EMERGING INFECTIOUS DISEASES Basic Field Epidemiology Session 2 – Overview of Epidemiology.
Mad Cow Disease Making sense of the headlines by Trevor Murdock.
EPIDEMIOLOGY The study of the distribution and determinants of health related states and events in specified population and application of this.
RISK COMMUNICATION APPROACH TSEAC 15 December 2006 Mark Weinstein, Ph.D. FDA, Center for Biologics Evaluation and Research.
Environmental Risk Analysis Chapter 6 © 2007 Thomson Learning/South-WesternCallan and Thomas, Environmental Economics and Management, 4e.
Contagious Bovine Pleuropneumonia CBPP. Center for Food Security and Public Health Iowa State University 2006 Overview Cause Economic impact Distribution.
BSE: World update FDA TSE Advisory Committee Gaithersburg, MD September 18, 2006 Lisa A. Ferguson, DVM Senior Staff Veterinarian USDA, APHIS, Veterinary.
Microbes and Diseases Chapter 02. CREUTZFELDT-JAKOB DISEASE Prion.
Preliminary Risk Assessment Model for U.S. Plasma Derivatives and vCJD Steven Anderson, PhD, MPP Office of Biostatistics & Epidemiology Center for Biologics.
Risk Assessment: Questions to the Committee 1.What estimate(s) should be used to reflect the prevalence of vCJD in the U.K.? Proposal: We propose using.
Blood-borne vCJD risk: in UK and other European populations Sheila M. Bird MRC Biostatistics Unit, CAMBRIDGE.
Topic 1: FDA Draft Guidance “Revised Preventive Measures to Reduce the Possible Risk of Transmission of CJD and vCJD by Blood and Blood Products” Dorothy.
David M. Asher, MD Division of Emerging & Transfusion-Transmitted Diseases Office of Blood Research & Review Center for Biologics Evaluation & Research.
United States Department of Agriculture Food Safety and Inspection Service Uday Dessai, MS, Ph.D., M.P.H. Director, Microbiology Division Office of Public.
1 A Simulation Model to Quantify the Spread of BSE in the United States Joshua Cohen and George Gray Harvard Center for Risk Analysis Harvard School of.
INTEGRATED CONTROLS DIVISION Cross Compliance Farm Advisory Service Training 2016 SMR 5 ‘ Hormone Ban’
August 2008 Bovine Spongiform Encephalopathy (BSE) Billy Moss Area Livestock Teacher North Region Agricultural Education February 2004.
Legal framework of TSE surveillance Workshop on Prevention, Control and Eradication of Transmissible Spongiform Encephalopathies (TSE) Serbian Ministry.
By: Terry Bender and Dustin Rozier Students of Dr. James Corbett Lowndes County High School Valdosta, Georgia November, 2002.
United States Department of Agriculture Food Safety and Inspection Service Non-O157 STEC: What We Know and What’s Next Elisabeth Hagen, M.D. Office of.
Question 1 A new test to diagnose urinary tract infections (UTIs) is being evaluated. The sensitivity of the test is 70% and the specificity is 90%. In.
(Bovine spongiform encephalopathy)
Bovine Spongiform Encephalopathy Variant Creutzfeldt-Jakob disease
Brain Trust Chapt 22: Origins
Frequently Asked Questions About BSE
FDA TSE Advisory Committee Meeting
Presentation transcript:

Analysis to Inform Decisions: Evaluating BSE Joshua Cohen and George Gray Harvard Center for Risk Analysis Harvard School of Public Health

Contributors Harvard Center for Risk Analysis Harvard Center for Risk Analysis Joshua T. Cohen Joshua T. Cohen Keith Duggar Keith Duggar George M. Gray George M. Gray Silvia Kreindel Silvia Kreindel Center for Computational Epidemiology, College of Veterinary Medicine, Tuskegee University Center for Computational Epidemiology, College of Veterinary Medicine, Tuskegee University Hatim Gubara Hatim Gubara Tsegaye HabteMariam Tsegaye HabteMariam David Oryang David Oryang Berhanu Tameru Berhanu Tameru Harvard Center for Risk Analysis Harvard Center for Risk Analysis Joshua T. Cohen Joshua T. Cohen Keith Duggar Keith Duggar George M. Gray George M. Gray Silvia Kreindel Silvia Kreindel Center for Computational Epidemiology, College of Veterinary Medicine, Tuskegee University Center for Computational Epidemiology, College of Veterinary Medicine, Tuskegee University Hatim Gubara Hatim Gubara Tsegaye HabteMariam Tsegaye HabteMariam David Oryang David Oryang Berhanu Tameru Berhanu Tameru

What USDA Asked Us to Do Identify and characterize possible sources for BSE (or a TSE disease with similar clinical and pathologic signs as BSE - will refer to as BSE for brevity) infectivity in U.S. cattle Identify and characterize possible sources for BSE (or a TSE disease with similar clinical and pathologic signs as BSE - will refer to as BSE for brevity) infectivity in U.S. cattle Identify and characterize pathways for cattle-derived BSE infectivity in the U.S. cattle herd or human food supply Identify and characterize pathways for cattle-derived BSE infectivity in the U.S. cattle herd or human food supply Evaluate implications over time of possible introduction of BSE into US system Evaluate implications over time of possible introduction of BSE into US system

Why We Chose a Simulation Approach No historical data - build understanding up from biology, agriculture, etc. No historical data - build understanding up from biology, agriculture, etc. Time matters - e.g., incubation period of BSE Time matters - e.g., incubation period of BSE Allow quantitative comparison of importance of different pathways of spread and different risk management Allow quantitative comparison of importance of different pathways of spread and different risk management Can help focus collection of information Can help focus collection of information

Learning from UK Experience We assume the prevailing hypothesis of UK BSE spread is correct:

Model Overview Cattle Population Number Infected Number Clinical Slaughter Rendering and Feed Production Infectivity Sources Human Food Disposal Death and Disposal Other Uses and Elimination from System Other Protein Sources Feed Administered to Cattle Death / Rendering

Cattle Dynamics

Key Assumptions - Susceptibility

Infectivity Level in Bovine vs. Time Since Infection

Distribution of Infectivity Relative Infectivity of Specific Tissues Specified from an Infected Bovine (Based on [SSC, 1999a]) a

Slaughter Process Sick Animal Characteristics Antemortem Inspection Disposition of Brain Stunning Exsanguination Tissues to rendering SplittingPostmortem Inspection Tissues for Possible Human Consumption AMR/ Spinal Cord/DRG Processing Out

Rendering and Feed Production Tissues to rendering Prohibited MBM production Prohibited feed production Feeding of cattle on farm Non-prohibited MBM production Non-Prohibited feed production Blood

Analyses Base Case Base Case Assume BSE not currently present in U.S. Assume BSE not currently present in U.S. Introduce 10 BSE infected animals (also simulated importation of 1 to 500 BSE infected cows) Introduce 10 BSE infected animals (also simulated importation of 1 to 500 BSE infected cows) Follow for 20 years Follow for 20 years Example Risk management Options Example Risk management Options Ban on rendering cattle that die on farm Ban on rendering cattle that die on farm UK-style “Specified Risk Material” ban UK-style “Specified Risk Material” ban Test with introduction of 10 infected animals and follow for 20 years Test with introduction of 10 infected animals and follow for 20 years Others Others Potential for pre-1989 imports from England to introduce BSE to U.S. Potential for pre-1989 imports from England to introduce BSE to U.S. Switzerland Switzerland Spontaneous Spontaneous Scrapie as source Scrapie as source

Model is Probabilistic Initialize Model Run Simulation Record Results Run 3 Run 2 Run 1 … Run 1000 Number of Infected Cattle over 20 Years

Results: Base Case Few new cases of BSE Few new cases of BSE mean = 3 and 95th percentile = 11 mean = 3 and 95th percentile = 11 Primarily through feed ban leaks Primarily through feed ban leaks 40% of animals predicted to die on farm introduce 96% of infectivity to system 40% of animals predicted to die on farm introduce 96% of infectivity to system BSE gone within 20 years of introduction BSE gone within 20 years of introduction

Base Case Results (continued) Little infectivity for potential human exposure (mean 35 cattle oral ID50s, 95th 170) Little infectivity for potential human exposure (mean 35 cattle oral ID50s, 95th 170) Brain26% Brain26% Beef on bone11% Beef on bone11% AMR meat56% AMR meat56% Spinal cord5% Spinal cord5% Conservative assumptions (e.g., no change if case detected) Conservative assumptions (e.g., no change if case detected)

Base Case – Summary

Base Case - Summary

Number of Cattle Infected: Probability of Prevalence Value Exceeding Zero

Base Case - Summary Number of Cattle Infected: Range of Prevalence Values

Base Case – Summary Number of Cattle Clinical: Probability of Prevalence Exceeding Zero

Base Case – Changes Over Time Number of Cattle Clinical: Range of Prevalence Values

Model Predictions for More Substantial Imports of Infected Cattle Number of BSE-Infected Cattle Imported Additional Infected Cattle

Model Predictions for More Substantial Imports of Infected Cattle Number of BSE-Infected Cattle Imported Number of ID 50 s Available for Potential Human Consumption

Key Sources of Uncertainty Influencing the Predicted Number of Infected Cattle

Key Sources of Uncertainty Influencing Predicted Human Exposure (ID 50 s Available for Human Consumption)

Key Management Points Spread in cattle herd Spread in cattle herd Mostly due to leaks in FDA feed ban and some maternal transmission Mostly due to leaks in FDA feed ban and some maternal transmission Animals that die on farm with provide greatest infectivity to animal feed system Animals that die on farm with provide greatest infectivity to animal feed system Potential human exposure Potential human exposure Handling of brain and spinal cord in processing very important Handling of brain and spinal cord in processing very important Primary routes of exposure are cattle brain, spinal cord, beef on bone and AMR meat Primary routes of exposure are cattle brain, spinal cord, beef on bone and AMR meat

Imports from England Before 1989 Evaluated potential for 173 (of 334) English imports not known to have been destroyed to introduce infectivity to U.S. cattle and implications Evaluated potential for 173 (of 334) English imports not known to have been destroyed to introduce infectivity to U.S. cattle and implications Used information on birth year, export year, animal type and sex, last sighting and more to estimate likelihood and potential magnitude of introductions of BSE infectivity to U.S. cattle feed Used information on birth year, export year, animal type and sex, last sighting and more to estimate likelihood and potential magnitude of introductions of BSE infectivity to U.S. cattle feed Used model to look at new BSE cases if introduction of different sizes did occur Used model to look at new BSE cases if introduction of different sizes did occur

Cumulative Distribution for the U.S. Cattle Exposure to Cattle Oral ID50s from Animals Imported from the UK During the 1980s

Cumulative Distribution for the Number of BSE-Clinical Cattle in the Year 2000 for Different Levels of Infectivity Introduced via Import of UK Cattle During the 1980s

Strengths of Analytic Approach Identify key assumptions and data Identify key assumptions and data Understand relative importance of different paths Understand relative importance of different paths Compare relative effectiveness of different risk management measures Compare relative effectiveness of different risk management measures Facilitates value of information (VOI) analysis to identify critical research areas Facilitates value of information (VOI) analysis to identify critical research areas

Weaknesses of Analytic Approach Overconfidence in results? Overconfidence in results? Dependent on underlying structure and assumptions Dependent on underlying structure and assumptions Difficulty in calibration/validation Difficulty in calibration/validation What is the alternative? What is the alternative?